These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2304580)

  • 1. [Anaphylaxis following use of polidocanol].
    Stricker BH; van Oijen JA; Kroon C; Ovink AH
    Ned Tijdschr Geneeskd; 1990 Feb; 134(5):240-2. PubMed ID: 2304580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology.
    Rabe E; Pannier F
    Dermatol Surg; 2010 Jun; 36 Suppl 2():968-75. PubMed ID: 20590702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polidocanol (aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias.
    Goldman PM
    J Dermatol Surg Oncol; 1989 Feb; 15(2):204-9. PubMed ID: 2644330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polidocanol (Varithena) for varicose veins.
    Med Lett Drugs Ther; 2015 Aug; 57(1474):111-2. PubMed ID: 26218793
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible ischaemic neurological deficit after sclerotherapy of varicose veins.
    Van der Plas JP; Lambers JC; Van Wersch JW; Koehler PJ
    Lancet; 1994 Feb; 343(8894):428. PubMed ID: 7905592
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of varicose tributaries with sclerotherapy with polidocanol 0.5 % foam.
    Reich-Schupke S; Weyer K; Altmeyer P; Stücker M
    Vasa; 2010 May; 39(2):169-74. PubMed ID: 20464673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for the sclerosing agent polidocanol (aetoxisclerol dexo, aethoxisklerol kreussler).
    Guex JJ
    J Dermatol Surg Oncol; 1993 Oct; 19(10):959-61. PubMed ID: 8408916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regarding extensive tissue necrosis following high concentration sclerotherapy for varicose veins.
    Fisher DA
    Dermatol Surg; 2000 Nov; 26(11):1082. PubMed ID: 11096404
    [No Abstract]   [Full Text] [Related]  

  • 10. Ischaemic neurological deficit after sclerotherapy.
    Trenkwalder P; Lydtin H
    Lancet; 1994 Mar; 343(8900):794. PubMed ID: 7907752
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.
    King JT; O'Byrne M; Vasquez M; Wright D;
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):784-93. PubMed ID: 26384639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Australian polidocanol (aethoxysklerol) study. Results at 2 years.
    Conrad P; Malouf GM; Stacey MC
    Dermatol Surg; 1995 Apr; 21(4):334-6; discussion 337-8. PubMed ID: 7728486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized retiform purpura after accidental intra-arterial injection of polidocanol.
    Yébenes M; Gilaberte M; Toll A; Barranco C; Pujol RM
    Acta Derm Venereol; 2005; 85(4):372-3. PubMed ID: 16191871
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of Aethoxysklerol® (polidocanol) 0.5%, 1% and 3% in comparison with placebo solution for the treatment of varicose veins of the lower extremities in Chinese patients (ESA-China Study).
    Zhang J; Jing Z; Schliephake DE; Otto J; Malouf GM; Gu YQ
    Phlebology; 2012 Jun; 27(4):184-90. PubMed ID: 22045827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke after varicose vein foam injection sclerotherapy.
    Forlee MV; Grouden M; Moore DJ; Shanik G
    J Vasc Surg; 2006 Jan; 43(1):162-4. PubMed ID: 16414404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergic reactions to polidocanol for vein sclerosis. Two case reports.
    Feied CF; Jackson JJ; Bren TS; Bond OB; Fernando CE; Young VC; Hashemiyoon RB
    J Dermatol Surg Oncol; 1994 Jul; 20(7):466-8. PubMed ID: 8034842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polidocanol: the perfect "solution".
    Weiss RA
    J Dermatol Surg Oncol; 1994 Jul; 20(7):465. PubMed ID: 8034841
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anaphylaxis following administration of polidocanol].
    Klein Rouweler BJ
    Ned Tijdschr Geneeskd; 1990 Mar; 134(11):553. PubMed ID: 2320151
    [No Abstract]   [Full Text] [Related]  

  • 19. The French polidocanol study on long-term side effects: a survey covering 3,357 patient years.
    Guex JJ; Schliephake DE; Otto J; Mako S; Allaert FA
    Dermatol Surg; 2010 Jun; 36 Suppl 2():993-1003. PubMed ID: 20590706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial infarction after ultrasoundguided foam sclerotherapy for varicose veins--a case report and review of the literature of a rare but serious adverse event.
    Engelberger RP; Ney B; Clair M; Dabiri A; Alatri A; Mazzolai L; Kern P
    Vasa; 2016; 45(3):255-8. PubMed ID: 27129073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.